Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2014 and based in Tokyo, Japan, Beyond Next Ventures Inc. specializes in supporting deep-tech startups. The firm primarily invests in seed to Series A stages and has a portfolio that includes notable companies like CureApp and SUSMED. They focus on transitioning research from academia into market-ready solutions.
Beyond Next Ventures invests in seed-stage deep-tech startups, primarily in Japan and India. Their investment sectors include healthcare, climate technology, agriculture, food, artificial intelligence, and biotechnology. The firm provides financial support, business planning resources, and access to incubation facilities to assist entrepreneurs in their commercialization efforts.
Notable portfolio companies include CureApp, Japan's first digital therapeutics product for medical institutions; exMedio, acquired by Mynavi in April 2019; SUSMED, a blockchain-enabled digital therapeutics platform that went public in December 2021; and GigIndia, acquired by PhonePe in March 2022.
Submit through their form at beyondnextventures.com.
Beyond Next Ventures runs the initiative 'PEAK TRIAL: CONTINUUM,' which supports entrepreneurs with prior startup experience in the deep-tech sector.
Yes, Beyond Next Ventures often leads investment rounds in their portfolio companies, particularly in the seed stage.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth potential and align with their focus areas.
Details on the exact size of their current fund are not publicly disclosed, but they actively invest in seed to Series A stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.